Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

ACCC President Dr. David R. Penberthy's final Tech Talk featured 4 panelists, who shared their perspectives on how technologies like artificial intelligence, machine learning, and the use of big data are currently impacting cancer care delivery, as well as their vision of the ideal future state.
Over half of patients newly diagnosed with multiple myeloma are not eligible for transplant due to age or other major health problems. Listen as Dr. Yee provides treatment planning options available to patients who are ineligible for transplant.
TACOS Spring Conference April 22, 2023 AGENDA Saturday, April 22, 2023 8:00 AM Registration Open / Resource Center 9:00 AM Welcome & Introductions Tomislav Dragovich, MD, PhD President, The Arizona Clinical Oncology Society Banner Md Anderson Cancer Canter Raju Vaddepally, MD President Elect, The Arizona Clinical Oncology Society Yuma Regional Medical Center …
Microsoft Word - AMCCBS Best of CCC Front Matter 3.3.23.docx Best of Community Cancer Care Workshop at AMCCBS March 8, 2023 Washington DC | District of Columbia At the end of this educational activity, participants should be able to: • Review highlights of the advances in clinical and translational research presented at recent national clinical conferences • Provide opportunities …
Advances in HER2 Positive Breast Cancer The ESHOS Review of San Antonio Breast Cancer Symposium Ajay Dhakal MBBS Wilmot Cancer Institute University of Rochester Medical Center Disclosures • Advisory Board: Gilead, AstraZeneca • Honorarium: MJH Life Sciences (OncLive), WebMD Slides from past conferences: Permission received from original presenters (Hurvitz, …
White title slide Molecular Tumor Board Mark E. Burkard MD PhD Mary and Rob Gooze Chair in Metastatic Breast Cancer University of Wisconsin- Madison Disclosures M.E.B. declares the following: • Strata Oncology (Medical Advisory Board) • Abbvie, Arcus, Apollomics, Elevation Oncology, Genentech, Puma, Loxo Oncology, Seagen (Research funding) • Novartis, Strata Oncology …
Advances in HER2 Positive Breast Cancer The ESHOS Review of San Antonio Breast Cancer Symposium Ajay Dhakal MBBS Wilmot Cancer Institute University of Rochester Medical Center Disclosures • Advisory Board: Gilead, AstraZeneca • Honorarium: MJH Life Sciences (OncLive), WebMD Slides from past conferences: Permission received from original presenters (Hurvitz, …
White title slide Molecular Tumor Board Mark E. Burkard MD PhD Mary and Rob Gooze Chair in Metastatic Breast Cancer University of Wisconsin- Madison Disclosures M.E.B. declares the following: • Strata Oncology (Medical Advisory Board) • Abbvie, Arcus, Apollomics, Elevation Oncology, Genentech, Puma, Loxo Oncology, Seagen (Research funding) • Novartis, Strata Oncology …
Agenda Subject to Change WVOS 2023 Spring Conference March 24, 2023 Agenda 7:00 AM Registration Open, Breakfast Served & Networking in Resource Center 8:00 AM Welcome & Introductions Ghulam Abbas, MD, FACS President, West Virginia Oncology Society 8:15 AM Clinical Updates on CNS Tumors Sonikpreet Aulakh, MBBS, MD West Virginia University …
SABCS Review Localized Therapy: Updates from a Surgery Perspective March 4, 2023 Anna Weiss MD Associate Professor, Surgery, Medicine University of Rochester, Wilmot Cancer Institute Director, Breast Cancer Service Line, Comprehensive Breast Care Center, Breast Surgery Disclosures ▪ Sponsored research agreement with prior institution, from Myriad Laboratories …
Updates in Triple Negative Breast Cancer Shipra Gandhi, MD Assistant Professor of Oncology Roswell Park Comprehensive Cancer Center Empire State Hematology and Oncology Review of San Antonio Breast Cancer Symposium Disclosures • Consulting - Astrazeneca EARLY - STAGE Role of platinum in TNBC Carboplatin increases pCR rate to >50% with/without …
SABCS Review Localized Therapy: Updates from a Surgery Perspective March 4, 2023 Anna Weiss MD Associate Professor, Surgery, Medicine University of Rochester, Wilmot Cancer Institute Director, Breast Cancer Service Line, Comprehensive Breast Care Center, Breast Surgery Disclosures ▪ Sponsored research agreement with prior institution, from Myriad Laboratories …
ASSOCIATION OF COMMUNITY CANCER CENTERS 1 An Innovative Approach to Navigating Patients Through Cancer Diagnostics ASSOCIATION OF COMMUNITY CANCER CENTERS A s advancements in cancer diagnostics have pro-pelled precision medicine forward, next genera-tion sequencing (NGS) technology has become a popular way to perform multigene testing in patients with cancer.1 …
Marty Makary, MD, MPH, discusses the American healthcare cost crisis, in his keynote address at the North Carolina Oncology Association and South Carolina Oncology Society annual joint conference.
Hormone receptor-positive breast cancer Ruth O’Regan, MD Chair and Charles A. Dewey Professor, Department of Medicine Associate Director for Education and Mentoring, Wilmot Cancer Institute University of Rochester Disclosures I have served as an advisor for PUMA, Lilly, Pfizer, Seagen, Novartis, Astra-Zeneca and have served on DSMB for Gilead All slides included …
Survivorship Update SABCS 2022 Tracey O’Connor, MD Associate Professor of Oncology Roswell Park Comprehensive Cancer Center Disclosures/Conflicts of Interest • None SABCS 2024 Highlights • GS4-09 Pregnancy Outcome and Safety of Interrupting Therapy for women with Endocrine Responsive Breast Cancer: Primary Results from the POSITIVE trial Partridge et al. • …
PowerPoint Presentation ESHOS SABCS 2022 Review: Genomic Update Seth A. Wander, MD, PhD Assistant Professor of Medicine Harvard Medical School Massachusetts General Hospital swander@mgh.harvard.edu Disclosures • Consulting/Advisory Board: Biovica, Eli Lilly,Foundation Medicine, Hologic, Pfizer, Puma Biotechnology, Veracyte • Education/Speaking: Eli Lilly, Guardant …
PowerPoint Presentation Review of the San Antonio Breast Cancer Symposium Simon Fung-Kee-Fung, MD March 4, 2023 Localized Therapy: Radiation Oncology Disclosures • None Outline: RT Advances = Less Toxicity • New Fractionation Schemes (A Review) – Early Stage Breast Cancer – PostMastectomy Radiation Therapy • New(ish) Technology – VMAT, Protons oh my! …